Important Labeling Information
Study Information
A summary of the study published by Jick SS, Kaye JA, Russmann S, Jick H (Contraception.
2006;73:223-228). Risk of nonfatal venous thromboembolism in women using a contraceptive trandsdermal patch and
oral contraceptives containing norgestimate and 35µg of ethinyl estradiol can be found by clicking the following
link:
http://www.ncbi.nlm.nih.gov
A summary of the study published by Cole JA, Norman H, Doherty M, Walker AM (Obstetrics and Gynecology.
2007:109:339-346). Venous Thromboembolism, Myocardial Infarction, and Stroke Among Transdermal Contraceptive System Users
can be found by clicking the following link:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearc
h=17267834&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.P
ubmed_RVAbstractPlus
A summary of the publication by Jick S, Kaye JA, Li L, Jick H (Contraception. 2007;76:4-7). Further Results
on the Risk of Non-Fatal Venous Thromboembolism in users of the contraceptive patch compared to users of oral contraceptives
containing Norgestimate and 35µg of EE can be found by clicking the following link:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearc
h=17586129&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.P
ubmed_RVAbstractPlus
A synopsis of the study conducted by the Boston Collaborative Drug Surveillance Program (BCDSP). Postmarketing
Study of ORTHO EVRA® and Levonorgestrel Oral Contraceptives Containing Hormonal Contraceptives with 30µg of EE in Relation to Non-Fatal
Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction can be found by clicking the following link:
http://download.veritasmedicine.com/PDF/CR014383_REF1.pdf
To obtain the full BCDSP study report, please call the Ortho-McNeil Janssen Scientific Affairs, LLC Customer Communication Center at 1-800-526-7736.
